Sustained clinical and histopathological remission in a patient with eosinophilic esophagitis and type 2 comorbidities after 18 months of discontinuation of dupilumab

Simple item page
dc.contributor.authorVíctor González-Uribe
dc.contributor.authorCarlos Acosta Rodríguez-Bueno
dc.contributor.authorZaira Mojica-González
dc.contributor.authorAndrea Malagón‐Liceaga
dc.contributor.authorMartín Roberto Basile-Álvarez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:48:32Z
dc.date.available2026-03-22T20:48:32Z
dc.date.issued2023
dc.identifier.doi10.22541/au.168804227.77031880/v1
dc.identifier.urihttps://doi.org/10.22541/au.168804227.77031880/v1
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/84191
dc.language.isoen
dc.sourceUniversidad La Salle
dc.subjectEosinophilic esophagitis
dc.subjectDupilumab
dc.subjectDiscontinuation
dc.subjectMedicine
dc.subjectGastroenterology
dc.subjectInternal medicine
dc.subjectDermatology
dc.subjectEsophagitis
dc.subjectEosinophilia
dc.titleSustained clinical and histopathological remission in a patient with eosinophilic esophagitis and type 2 comorbidities after 18 months of discontinuation of dupilumab
dc.typepreprint

Files

Collections

Artículo Científico (Preprint)